RARB and lung cancer: It was found by using methylation‐specific PCR that the high percentage of promoter methylation in the RARβ and RASSF1A genes promotes lung cancer, such that carriers who have aberrant methylation in the promoter of two genes are at a higher risk of lung cancer than carriers of only one gene.